Camillo D Ricordi

This inventor holds 26 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Diabetes Treatment. Top assignees: University of Miami, Biorep Technologies, Inc., Nogra Pharma Limited. Active years: 1998-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camillo D Ricordi. Retrieved from https://idiyas.com/inventor/camillo-d-ricordi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 12)

% Patents Active = 73.1

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 165(Granted Patents)

Location History:

Hibiscus Island, Miami Beach, FL (US) (1999)
Miami Beach, FL (US) (1998 - 2003)
Miami, FL (US) (2002 - 2022)

Company Filing History:

Biorep Technologies, Inc.

Converge Biotech Inc.

patents

5. 1 out of 1,960

University of Pittsburgh

patents

6. 1 out of 524

Wake Forest University

patents

7. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2022

Loading Chart...

Areas of Expertise:

Insulin-Producing Cells

Pancreatic Islets

Organ Preservation

Cell Culture Platforms

Hybrid Devices

Oxygen Release

Transplantation

Hematopoietic Cells

Volatile Gas Anesthetics

Encapsulation

Cell Therapies

Surgical Devices

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466255 - Methods and compositions for converting non-endocrine pancreatic tissue into insulin-producing cells (2022-10-11),

2. 10443056 - Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation (2019-10-15),

3. 10081809 - Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation (2018-09-25),

4. 9980923 - Stable liquid formulations of volatile gas anesthetics (2018-05-29),

5. 9308269 - Stable liquid formulations of volatile gas anesthetics (2016-04-12),

6. 9175254 - Enhanced oxygen cell culture platforms (2015-11-03),

7. 8986725 - Silicone-peroxide compositions for long-term, controlled oxygen release (2015-03-24),

8. 8865427 - Perifusion device (2014-10-21),

9. 8785178 - Perifusion device (2014-07-22),

10. 8728520 - Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same (2014-05-20),

11. 8702684 - Therapeutic hybrid implantable devices (2014-04-22),

12. 8551770 - Enhanced oxygen cell culture platforms (2013-10-08),

13. 8355692 - System and method for transmitting user data received by an authorized approver (2013-01-15),

14. 8263389 - Perifusion device (2012-09-11),

15. 7910359 - Hybrid device for cell therapies (2011-03-22),

Title: The Innovative Journey of Camillo Ricordi

Introduction: Camillo Ricordi, a distinguished inventor based in Miami, FL, has made significant contributions to the field of medical innovation and research.

Latest Patents: Camillo Ricordi holds several patents related to advancements in organ transplantation techniques and regenerative medicine, with a focus on improving patient outcomes and quality of life.

Career Highlights: Throughout his illustrious career, Camillo Ricordi has been at the forefront of pioneering research in diabetes treatment, particularly in the development of novel therapies and technologies for managing the condition.

Collaborations: Ricordi has collaborated with leading medical institutions, universities, and research centers worldwide to further his groundbreaking work in the field of regenerative medicine and transplantation.

Conclusion: Camillo Ricordi's dedication to innovation and his relentless pursuit of medical advancements continue to inspire and shape the future of healthcare.

Profile summary based on public USPTO records.